Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia
Lindström, Vesa; Aittoniemi, Janne; Salmenniemi, Urpu; Käyhty, Helena; Huhtala, Heini; Sinisalo, Marjatta (2019)
2019
Human Vaccines and Immunotherapeutics
Yhteiskuntatieteiden tiedekunta - Faculty of Social Sciences
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Samankaltainen aineisto
Näytetään aineisto, joilla on samankaltaisia nimekkeitä, tekijöitä tai asiasanoja.
-
Vaccine diplomacy, vaccine nationalism or vaccine equity?: The EU’s discourse on COVID-19 vaccination distribution and cultures of international anarchy
(2023)
Pro gradu -tutkielmaThe COVID-19 pandemic is an extensive world political challenge, a global “wicked problem” with potential societal changes. From the beginning of the COVID-19 outbreak, global power relations and diplomatic controversies ... -
Public health authorities' perceptions of, and strategies for, communicating and addressing vaccine hesitancy with and among healthcare workers in Europe : A mixed methods analysis of the European Joint Action on Vaccination survey, “Vaccine hesitancy and uptake: from research and practices to implementation”
(2022)
Pro gradu -tutkielmaReaching public health goals requires comprehensive and dependable communication strategies. The public is usually the target of public health communication, including vaccination communication. As the body of evidence ... -
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers : A randomised, controlled trial
(2022)
articleMenACYW-TT (MenQuadfi®) is a quadrivalent meningococcal tetanus toxoid conjugate vaccine licensed in Europe for use in individuals ≥12 months. This study assessed whether serogroup C immune responses with MenACYW-TT were ...
